Vivos Therapeutics, Inc. (VVOS) stock
VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.08−0.00 (-3.04%)
Close on Nov 17, 2026Market cap $1.60MP/E –Yield –
Vivos Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Vivos Therapeutics's price to sales ratio was 0.1× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.1× to 4.6×, with a median of 0.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | −0.9 |
| 2025 | Dec 31, 2025 | 1.0× | −0.4 |
| 2024 | Dec 31, 2024 | 1.4× | +0.4 |
| 2023 | Dec 29, 2023 | 1.0× | +0.5 |
| 2022 | Dec 30, 2022 | 0.6× | −2.7 |
| 2021 | Dec 31, 2021 | 3.3× | −3.2 |
| 2020 | Dec 31, 2020 | 6.5× | – |
See a number that looks wrong?